@OncEd Presents Dr. David Zloty – Mohs Surgery for Melanoma and Merkel – Canadian Melanoma Conference 2015
Author: admin
@OncEd Presents Dr. Heidi Wat – A Seven-Year analysis of Mitotic Rate & Sentinel Lymph Node Biopsy Status in Patients with Melanoma in Alberta From 2007-2013 – Canadian Melanoma Conference 2015
@OncEd Presents Dr. Chlo̩ Ward РThe Rate of Missed Melanoma in Sentinel Node Negative Patients: The Ottawa Experience РCanadian Melanoma Conference 2015
@OncEd Presents Dr. Claire Temple-Oberle – Interleukin-2 for In transit Melanoma – Canadian Melanoma Conference 2015
@OncEd Presents Dr. Jeff Sosman – Treatment of Non-BRAFV600E Melanoma With Targeted Therapy – Canadian Melanoma Conference 2015
@OncEd Presents Dr. Merrick Ross – Intralesional Therapy For Melanoma – Canadian Melanoma Conference 2015
@OncEd Presents Dr. Merrick I. Ross – The Role of Neo-Adjuvant Therapy In Resectable Advanced Melanoma – Canadian Melanoma Conference 2015
@OncEd Presents Dr. Lynne Robertson – Population Screening For Melanoma – An Alberta Trial – Canadian Melanoma Conference 2015
@OncEd Presents Dr. Jason Rivers – Diagnostic Advances In Melanoma Detection – Canadian Melanoma Conference 2015
@OncEd Presents Dr. Dayna Miyashiro – Immunotherapy In Stage III Melanoma – Canadian Melanoma Conference 2015
@OncEd Presents Dr. Iren Kossintseva – Melanoma Inflammatory Response Signature – Canadian Melanoma Conference 2015
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Cheryl Vidall, Head of Nursing and Governance at Alcura UK Limited, Alton, UK, discusses the challenges to adherence to oral cancer therapies, as well as the role of a multidisciplinary team approach for optimising safety and adherence. European Medical Journal Website: http://emjreviews.com/ Twitter: https://twitter.com/EMJReviews Facebook: https://www.facebook.com/emjreviews
@OncEd Presents Dr. David Hogg – Managing The Advanced Non-Melanoma Skin Cancers – Canadian Melanoma Conference 2015
@OncEd Presents Dr. Omid Hamid – PD1 Therapy and Biomarkers for Response – Canadian Melanoma Conference 2015
@OncEd Presents Dr. Axel Hauschild – Adjuvant Melanoma Treatment: Past, Present and Future – Canadian Melanoma Conference 2015
@OncEd Presents Dr. Femida Gwadry-Sridhar – Do We Really Need Big Data – Canadian Melanoma Conference 2015
@OncEd Presents Dr. Michael Davies – Clinical & Therapeutic Significance of the PI3K-AKT Pathway in Melanoma – Canadian Melanoma Conference 2015
@OncEd Presents Dr. Joel Claveau & Dr. Scott Ernst – A Practical Multi-Disciplinary Discussion of Challenging Cases in Melanoma – Canadian Melanoma Conference 2015
@OncEd Presents Dr. Marcus Butler – Immunotherapy for All: Next Steps When Current Therapies Fail – Canadian Melanoma Conference 2015
@OncEd Presents Dr. Marcus Butler – Immunotherapy for All: Next Steps When Current Therapies Fail – Canadian Melanoma Conference 2015
@OncEd Presents Dr. Boris Bastian – Towards an Integrated Taxonomy of Melanocytic Neoplasms – Canadian Melanoma Conference 2015
@OncEd Presents Dr. Eric Valli̬res РInnovation In Lung Cancer Surgery РCLCCO 2015
@OncEd Presents Dr. Glenwood Goss – Welcome From NCIC – CLCCO 2015
@OncEd Presents Dr. Sunil Verma – A National Strategy On Molecular Testing In NSCLC – CLCCO 2015
@OncEd Presents Dr. Yee Ung – A Canadian Radiation Oncologist Perspective – CLCCO 2015
@OncEd Presents Dr. Martin Reck – Lung Cancer: Today and Tomorrow – CLCCO 2015
@OncEd Presents Dr. Natasha Leigh – Third Generation EGFR TKI – CLCCO 2015
@OncEd Presents Dr. Gary Lee – Management of Malignant Pleural Effusions – CLCCO 2015
@OncEd Presents Dr. Rosalyn Juergens – Immunotherapy In NSCLC – CLCCO 2015
@OncEd Presents Dr. Laurie Gaspar – Lung Cancer Today: Maximizing the Therapeutic Ratio – CLCCO 2015
@OncEd Presents Dr. Krista Noonan – Debate: TKI in Adjuvant Setting For EGFR +VE Patients – No – CLCCO 2015
@OncEd Presents Dr. Jason Agulnik – Debate: TKI in Adjuvant Setting For EGFR +VE Patiens – Yes – CLCCO 2015
@OncEd Presents Dr. Paris Ingledew – Debate: Prophylactic Brain radiation For Extensive Stage Small Cell Cancer – Yes – CLCCO 2015
@OncEd Presents Dr. Patrick Cheung – Debate: Prophylactic Brain radiation For Extensive Stage Small Cell Cancer – No – CLCCO 2015
@OncEd Presents Dr. Charles Butts – Debate: Targeted Therapy Vs. Immunotherapy For First Line In SNCLC – NO – CLCCO 2015
@OncEd Presents Dr. Normand Blais – Debate: Targeted Therapy VS. Immunotherapy For First Line In NSCLC – YES – CLCCO 2015
@OncEd Presents Dr. Ross Camidge – The Changing World of Alk Mutations and Treatment – Lung Cancer – CLCCO 2015
@OncEd Presents Dr. Robert Kerbel – Anti-Angiogenic Therapies In Cancer – 2015
@OncEd Presents Dr. Alexander Lyon – Proteasome Inhibition – GCOS 2015
@OncEd Presents Dr. Lee Jones – Impairments In Cardiovascular Reserve Capacity And Efficacy of Exercise Countermeasures In Cancer – GCOS 2015
@OncEd Presents Dr. Michael Fradley – QT Prolongation And Other Electrophysiologic Considerations In Cancer Patients Undergoing Stem Cell therapy – GCOS 2015
@OncEd Presents Dr. Giorgio Minotti – Developing a Dedicated Cardio-Oncology Journal – GCOS 2015
@OncEd Presents Dr. Zaza Iakobishvili – Can Cardio-Oncology Deliver Improved Practice Internationally – GCOS 2015
@OncEd Presents Dr.Susan Dent – Establishing a Cardio-Oncology Clinic – GCOS 2015
@OncEd Presents Dr. Paul Richardson – Contemporary Treatment of Multiple Myeloma – GCOS 2015
@OncEd Presents Dr. Daniela Cardinale – The Practical Use of Cardiac Biomarkers – GCOS 2015
@OncEd Presents Dr. Ronald Schwartz – Leading Lessons of Radionuclide Angiocardiography – GCOS 2015
@OncEd Presents Dr. Anju Nohria – Autonomic Dysfunction in Patients Treated With Mediastinal or Neck Radiation – GCOS 2015
@OncEd Presents Dr. Dinesh Thavendiranathan – The Use of Strain And Newer Echocardiography Imaging Techniques – GCOS 2015
@OncEd Presents Dr. Sebastian Szmit – Is Dasatinib-Related Pulmonary Hypertension a Concern – GCOS 2015